Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.93 USD | +2.81% | +2.78% | +198.24% |
18/04 | JonesTrading Starts Rezolute With Buy Rating, $10 Price Target | MT |
06/03 | Rezolute, Inc. Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+198.24% | 114M | |
+4.52% | 111B | |
+10.99% | 105B | |
-11.96% | 22.34B | |
-3.76% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-9.23% | 16.96B | |
+3.17% | 13.7B | |
+36.44% | 12.45B |
- Stock Market
- Equities
- RZLT Stock
- News Rezolute, Inc.
- Cantor Fitzgerald Adjusts Price Target on Rezolute to $5 From $7, Maintains Overweight Rating